|
MabVax Therapeutics Raises $3 Million In Common Stock Financing And An …
MarketWatch On July 7th, investors in the Series C Preferred Stock financing that closed in February of this year exercised warrants to purchase additional shares of MabVax Series C Preferred Stock. Total proceeds from the exercise of the C-1 warrants were $1.5 … |
